"THERE IS NO JOY IN LAMBEAU FIELD, MIGHTY AARON HAS SOLD OUT."

 "THERE IS NO JOY IN LAMBEAU FIELD, MIGHTY AARON HAS SOLD OUT."

(THE FINAL PARAGRAPH MIGHT BE THE MOST TELLING, AND IT HAS NOTHING TO DO WITH MEDICAL RESEARCH)

HERE IS A QUOTE, FROM THE PAT MCAFEE SHOW, THAT SHOULD TELL YOU ALL YOU NEED TO KNOW ABOUT AARON RODGERS:

“There’s a PC woke culture that exists, and there’s a cancel culture at the same time,” Rodgers said. “And it’s based on people’s own feelings of maybe personal miserability or distaste for their own situations or life, or maybe just enjoyment of holding other people down underneath their thumb.”

In AARON RODGERS reality:

- If you are a Teammate, Club Employee, Reporter, or Fan who is upset about Aaron Lying about being vaccinated,* it must be "personal miserability." 

*(Using the term "Immunized" was just an attempt to avoid answering the Question truthfully)

- If someone criticizes Rodgers for promoting Quack Remedies, (like those below), the answer is "distaste for their own situations or life."

- If the Federal Government Agencies, like the CDC, try to prohibit or prevent individuals from being harmed by using worthless treatments, it is "enjoyment of holding other people down underneath their thumb.”

I ASSUME THAT THE MAYO CLINIC, AND JOHNS HOPKINS ARE REPUTABLE ENOUGH SOURCES FOR EVALUATING TWO OF THE FAR RIGHTS MEDICAL "MIRACLES."

JOHNS HOPKINS WEBSITE. (10/16/2021)

Hydroxychloroquine

The antimalarial and antiinflammatory has not been shown in large randomized trials to yield benefit in the treatment of COVID-19 in hospitalized patients (RECOVERY trial), and concerns raised about cardiotoxicities in critically ill patients. It also appears to not offer prevention after exposure.The drug is not recommended by any mainstream experts or authorities.

MAYO CLINIC WEBSITE. (9/1/2021)

IVERMECTIN.

A Mayo Clinic infectious diseases expert offered a blunt assessment when asked about people's use of an unapproved horse drug to treat COVID-19. saying in part: "It's hard to explain."

Dr. Gregory Poland, head of Mayo Clinic's Vaccine Research Group, said on a Mayo Clinic Q&A podcast Monday the number of people "flocking" to the drug, ivermectin, is "astounding." Ivermectin is approved by the Food and Drug Administration (FDA) to treat specific instances of parasitic worms in humans, as well as some skin conditions. There is also an animal-grade version used to prevent parasites.

It is not an anti-viral drug, the FDA says, and there is mixed evidence at best right now that it is effective in dampening COVID-19.

Yet demand for ivermectin, driven by misinformation, has skyrocketed. The Centers for Disease Control and Prevention (CDC) said last week ivermectin prescriptions have gone up 24-fold compared to before the pandemic. There had been about 3,600  prescriptions per week prior to COVID — the week ending Aug. 13 saw 88,000 prescriptions dispensed.

"If I said to you, you know what, instead of an FDA-approved vaccine that's been tested in hundreds of thousands of people. Instead, let's take a drug that's used to treat parasites," Poland said on the Mayo Clinic podcast. "And many people are buying it over the counter in an animal treatment preparation that hasn't been studied for this, which makes people sick, can cause hallucinations, coma, and if you take it when you're pregnant, can cause birth defects, and let's use that instead."

In May, the University of Minnesota Medical School began a $1.5 million clinical trial of ivermectin to treat COVID-19. The school, as of Aug. 11, said existing trials show "mixed results," noting "there is insufficient data at this time to recommend its use in COVID-19." As for trials that suggest some potential benefit, the school says these studies are not peer-reviewed and have various flaws, including a small sample size and inconsistent dosage.

Poland described these existing studies as "very poorly conducted trials," noting the Cochrane Collaboration said there's no data to suggest ivermectin is effective at treating COVID-19.

Merck, which produces ivermectin and would benefit financially from a surge in sales, even said earlier this year there is "no scientific basis for a potential therapeutic effect against COVID-19," "no meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease," and a "concerning lack of safety data in the majority of studies."